Episode summary
In the first episode of the Cognitive Care Series, Mary Patterson, VP of Clinical and Regulatory at BrainCheck, talks with Dr. David Drover, anesthesiologist and professor emeritus of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine.
Dr. Drover leads an NIH-funded study that follows older orthopedic surgery patients for years after anesthesia to learn how their cognition changes. He explains how his team uses BrainCheck for long-term follow-up, shares what he has seen as an anesthesiologist about the aging brain, and makes his case for assessing cognition before surgery.
In this episode
- [00:00] Introduction
- [01:30] Why cognitive care matters for patient health
- [02:30] Why cognitive care matters for older patients heading into surgery
- [05:00] Dr. Drover’s current research
- [06:30] How the team uses BrainCheck
- [12:40] The cost of delirium
- [15:50] What a cognitive baseline could change in the operating room
- [18:00] One message for patients
An anesthesiologist on the aging brain
People now worry about their brains the way they have long worried about their hearts, Dr. Drover says: whether dementia is coming, or whether a medical event could leave them with less cognition later in life. Surgery is one of those events, and anesthesia is a hot topic in his field because of what it may do to older brains. Researchers have found that the risk of cognitive problems after surgery rises with age, and the reasons are still being worked out. Dr. Drover points to two open questions: the anesthetic itself and the body’s inflammatory response to surgery.
The research and how his team uses BrainCheck
Answering those questions takes measurement over time. Dr. Drover and his team at Stanford received an NIH grant to study cognition in older adults around the time of surgery. Each patient completes a baseline assessment before surgery and repeat assessments at one day, three months, and one year afterward, and five-year follow-ups are happening now.
In-person tools such as the MoCA demand a lot of staff time, and the study began during the COVID-19 pandemic, when in-person interactions were limited. Distance posed a second problem. Many patients travel hundreds, if not thousands, of miles for surgery, so bringing them back for repeat measurements a year or five years later was unrealistic.
The team needed an assessment that could be given remotely, both to work within pandemic restrictions and to follow patients who could not return to the hospital regularly. BrainCheck met that need, and the team has stayed with it through five years of follow-up. Dr. Drover says the workflow has been easy on his research coordinators and on patients, who log on to a digital assessment instead of making a whole-day trip to the hospital.
“The ability to do it remotely and do these long-term follow-ups, I felt, had no competition at that point in time.” Dr. David Drover
What a cognitive baseline matters before and after surgery
The baseline serves the study first. With each patient’s starting point on record, the team can track how cognition changes after anesthesia and surgery, and how it continues to change over the long term, which helps researchers understand the impact of anesthesia.
It matters just as much for the patient on the table. Mild impairment often isn’t obvious in conversation, so a patient can seem fine at a pre-anesthetic visit while carrying a cognitive problem no one has noticed. If a BrainCheck at that visit shows mild impairment, Dr. Drover says, the care team may be looking at a patient who will go on to have delirium after surgery. Research supports the link between cognitive impairment before surgery and a higher likelihood of delirium afterward.
Dr. Drover describes the clinical application as a work in progress. For a 78-year-old coming in for a hip replacement who tests as likely impaired, he would consider adjusting the anesthetic plan and adding support afterward, such as a family member or sitter close by and familiar items in the room.
The stakes are high because delirium is associated with longer hospital stays and higher costs. Patients are exposed to more hospital infections, and their families absorb added stress and expense. Dr. Drover says hospitals generally are not paid for the extra days, which is why he argues that assessing cognition before surgery will save them money afterward.
A message for patients
Dr. Drover says people are increasingly aware of their own cognition and health trajectory. A baseline gives them something to act on, from blood pressure and cholesterol to taking medications reliably, and room to prepare for surgery with prehabilitation. Even tackling one item on that list, he says, pays off over time.
“People who can get this testing done can change their own trajectory and do prehabilitation before any surgeries they may even have.” Dr. David Drover
About the guest
David Drover, MD, is an anesthesiologist and professor emeritus of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine. He has authored more than 100 publications and is affiliated with Stanford Bio-X and the Wu Tsai Neurosciences Institute.
[00:00:00]
Mary Patterson: Hello everyone, and welcome to our Cognitive Care Series. In each episode, we sit down with a clinician or industry expert to hear what they’re seeing in cognitive care and how it works in their practice. I’m Mary Patterson, VP of Clinical and Regulatory at BrainCheck. In my role, I collaborate with and support more than 500 practices focused on improving cognitive care for patients and caregivers alike. Neuroscience is my passion, and I’ve spent over a decade moving medical technologies forward through clinical research.
Today I’m thrilled to be joined by Dr. David Drover from Stanford University. Dr. Drover is an anesthesiologist and Professor Emeritus of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine. He has authored more than 100 publications and is affiliated with Stanford Bio-X and the Wu Tsai Neurosciences Institute. Stanford University has been a BrainCheck research partner for the past six years, and Dr. Drover has seen firsthand how digital cognitive assessments can shape patient care.
Today I’ll be asking Dr. Drover why cognition deserves attention in every patient’s care and what his research reveals about assessing it before surgery. We’ll focus on key truths, personal findings, and what he’s learned throughout his remarkable career that can help others in the space. Dr. Drover, thank you for joining us. I’ll begin with a broad question: why does cognitive care matter in patient health?
Dr. David Drover: Thank you. I think it helps us manage and predict the trajectory of the patient. We worry about patients’ hearts. We deal with them every day, and people worry about heart attacks and vascular disease. But people also worry about their brains and what’s going to happen with their brain next. We’ve reached a stage where people are asking whether they’re going to have dementia or Alzheimer’s, or whether something in their medical care will cause them to have less cognition later in life. Everyone ends up with some medical journey in their life, because that’s the nature of the human spirit. So I think we need to be more attuned to what’s going on with people’s cognition, help them manage it, and thus improve care as they grow older.
Mary Patterson: I couldn’t agree more about the accessibility of brain health. Why does this matter specifically for older patients heading into surgery?
Dr. David Drover: It’s a hot topic in the world of anesthesia right now. We give anesthesia to many millions of people every day worldwide, and many millions nationally. The majority of people who require anesthesia and surgery are over the age of 60 or 65. I hate to call that elderly, but they need something, whether it’s cancer, or wear and tear on the body, or a hip or knee replacement, or a cure for some ache or pain.
We tell patients, “I’m going to put you to sleep today.” But the truth is that anesthesia is not sleep. If you look at the brain, it’s closer to inducing a coma. We hate to tell our patients that. We don’t want to walk up and say, “I’m going to place you in a coma for a couple of hours while the surgeon does something.” But we’ll skip over that. In a young person, say under the age of 60, there’s no suggestion that people wake up different than when they went to sleep. Once you hit 60, 65 and older, the brain is not the same afterwards. We’re still delving into why. Is it the nature of the anesthetic? Is it the inflammatory reaction, the body’s response to surgery? What we do know is that if we know a patient’s neurologic baseline, we can do things to improve care and improve their trajectory after surgery. In other words, if we know where they stand cognitively beforehand, we can improve their cognition after surgery.
[00:05:00]
Mary Patterson: That makes sense. BrainCheck has been supporting a couple of other research programs in the same space, since assessing risk for delirium before and after surgery is a hot-button issue. But that’s a nice pivot to your work specifically. What is your current research focused on, and how are you using BrainCheck within that workflow?
Dr. David Drover: We applied for and received a very large NIH grant, funded in 2020.
Mary Patterson: Congratulations!
Dr. David Drover: Thank you. The whole idea of the grant was to look at neurocognition in the elderly around the time of surgery. We decided to study orthopedic patients because it’s a very consistent surgery, and many of the elderly need hips, knees, and other orthopedic procedures. We also knew from the literature that a lot of these same patients, having the same surgery, have neurocognitive issues afterwards, and we wanted to look deeper into that. So we built a very comprehensive database. We prospectively enrolled patients coming for surgery and did baseline neurocognitive assessments. We then continued to follow them postoperatively at one day, three months, and one year, and we’re working on the five-year follow-up as we speak, trying to understand the trajectory of neurocognitive health after anesthesia and surgery.
It segues into another story. In NIH lingo, we got our Notice of Award on September 1st, 2020. That was a unique date because the COVID pandemic was roaring, and it was the second closure of our hospital at Stanford. We closed the hospital to isolate patients and deal with the possible wave of COVID patients. But that didn’t mean our NIH funding stopped, and people were still requiring surgery. So this gave us a great opportunity to use BrainCheck. We went in thinking we might have to use some of the more labor-intensive assessments, such as the MoCA, but realistically we couldn’t inflict that on the patients. I’m trying to say this in a nice way, but everyone was very leery of any additional face-to-face contact. Even our Institutional Review Board was a little suspicious about us having that much contact with our patients.
Mary Patterson: You don’t want to add additional burden on the patient side. The patient risk-benefit considerations were so challenging at that time for everyone in healthcare, but particularly for research.
Dr. David Drover: Sure. Also, NIH grants are not lucratively funded, and the manpower to do all those one-on-one assessments would have strained the budget we needed to complete the research we really wanted to do. BrainCheck had the ability to do it remotely and do these long-term follow-ups, and I felt it had no competition at that point in time. We have patients who travel hundreds if not thousands of miles to get their surgery done, and realistically that wasn’t going to be possible with a lot of the in-person neurocognitive testing of the last half dozen years. BrainCheck allowed us to continue to get full enrollment and to get all the assessments we needed.
Mary Patterson: Fantastic. I was going to congratulate you on the benefit of having such long-term results worked into your study. It’s very exciting on the research side to see five-year follow-ups that are successful. It sounds like what made BrainCheck most attractive for this work was its remote capability. Following the pandemic period, have you continued the remote workflow, or has some of that testing transitioned to in person?
Dr. David Drover: One of my co-investigators is a neurologist who works in the Alzheimer’s research center at Stanford. In consultation with him, we felt that reviewers might question BrainCheck when we came to publication years down the road. So with the final patients, we went back and did some MoCA testing for mathematical analysis.
[00:10:00]
Mary Patterson: As a reference.
Dr. David Drover: Yes. We haven’t done that analysis yet, but it’s still in the plan. We did some because I had the manpower to execute it. Other than that, we’ve stayed with BrainCheck, and we’ve been happy with it because our patients are far and wide, and we’re now doing five-year follow-ups. I couldn’t imagine tracking all these patients down to do in-person testing. So we’ve stayed with BrainCheck all this time.
Mary Patterson: How have patients and clinical staff responded to the assessment? Can you detail the feedback you’ve heard from patients on the accessibility of remote testing? And has it been challenging for clinical research coordinators or other staff, given that this is outside what would be standard for them?
Dr. David Drover: It’s been really easy. Research moves on, other studies come along, and there are other distractions for the research team, especially my clinical research coordinators. They have to be flexible, and I have to cover salaries when the next study comes along. We slate these follow-ups and cognitive testing, and the advantage is that coordinators can slot this into a half hour of downtime. If they’re waiting for the next study, or I don’t have a clinical study going on that day, they can jump on a call and make sure the patients are completing their neurocognitive assessments with BrainCheck.
If a coordinator had to take a day or more to travel somewhere and do assessments, it wouldn’t be viable. It just would not work for my team. We’re stretched too thin to do the research we have to do. And patients aren’t going to come to the hospital. We’re calling them up at five years, or even at the one-year follow-up, and they’ve gone back to their lives. Even if they live only a mile away, and not to give Silicon Valley a hard time, you have to drive that mile, find parking, pay for parking at the hospital, wander around the maze of finding where you have to be, and get your testing done. It’s a whole day commitment for a patient. To be able to simply log on to a digital platform and get it done, I think the response rate for in-person testing would truly approach zero. It just would be nonviable.
Mary Patterson: Interesting. Building on that, adding a step to what’s already a very burdensome and busy preoperative workflow is not an easy task. At what stage are you in adopting the learnings from your research study into your clinical practice?
Dr. David Drover: We’re working on publishing. Publishing sounds boring, but I think it’s the only way to really change practice. I think practice is changing, but healthcare in this country is a machine that requires money, and every step that takes longer is a cost to the hospital. So there’s always pushback. I’m at the stage of trying to convince hospitals that preoperative cognitive assessments have to be done because they will save money postoperatively.
Say we do a BrainCheck on someone during their pre-anesthetic assessment, and it’s obvious they’re showing even mild impairment. These are the patients who go on to have episodes of delirium postoperatively. If a patient has delirium, that can easily extend their hospital stay by a day or two or more. Generally speaking, hospitals won’t get paid for that additional length of stay. They got paid for the main intervention they performed, and the complications that occur, including delirium, mean extended care that isn’t compensated, compared with bringing another procedure into the hospital. That’s just the business of running a hospital.
Mary Patterson: It might also result in additional interventional supports during that hospital stay.
Dr. David Drover: Almost certainly it would.
[00:15:00]
Dr. David Drover: Now, for the patient, of course, it’s “Wow, they had delirium.” They’re not the same afterwards. They’ve spent more days in the hospital and are more prone to hospital infections. The family is stressed, and it’s a financial stress on the family. There’s nothing good about spending extra days in the hospital. If anyone has the choice between being in the hospital or not, the answer is always “don’t be in the hospital.” So if we can do preoperative assessments and improve postoperative care and discharge, I think that can only be a win. It’s going to take a while for hospitals to see that, but I think that’s the trajectory we’re on.
Mary Patterson: Research is always the first step in updating guidelines, which then impacts reimbursement. But I think at this stage the impact on the patient side is pretty well understood. I want to go back to your hip replacement example from the outset. For a 78-year-old patient coming in for a hip replacement, where the test shows possible or likely impairment preoperatively, what specific adjustments do you make, or would you recommend making?
Dr. David Drover: It’s still a work in progress. But if that patient comes across my plate, we consider how to modify the anesthetic. A lot of the time we feel that a deeper general anesthetic is more prone to produce delirium afterwards. So we’re more likely to shift toward a regional anesthetic, meaning spinals or epidurals, where the patient receives light sedation or no sedation at all, thus protecting their brain.
We also know that if we can intervene more quickly postoperatively, patients recover better. That might mean having a sitter with them, or a family member immediately and always available afterwards, along with things that are familiar to them. We can do things that improve recovery. Is that important for the average 20-year-old? Maybe, but probably not to the degree it is for a 78-year-old. So we can really change the recovery trajectory if we know what’s coming.
I equate it to pneumonia. We don’t treat everyone with antibiotics if they don’t have pneumonia. You should only treat the patients who are at risk. I think a 78-year-old with a mild neurocognitive deficit preoperatively is at risk, and they should be treated as though they have a disease. If you do early intervention, you’ll get a better outcome.
Mary Patterson: It’s exciting to hear about your work and what we have to look forward to in informing cognitive care in the perioperative space. To conclude, if a clinician watching this wanted one sentence to share with their patients on this topic, why should older adults get a cognitive check before surgery? A cognitive check serves as a baseline that enables proactive brain health measures. What’s the one-sentence takeaway from you?
Dr. David Drover: More people are becoming aware of their own health, their own cognition, and their own trajectory. If we as a patient population, and everyone is a patient, get an idea of our baseline neurocognitive ability, we can change our own trajectory. Maybe I realize I have a mild neurocognitive deficit, so I’m going to eat better. We all like to say that. I’m going to sleep better, make sure I take my medications, and make sure my blood pressure and cholesterol are under control. I can do things to change the trajectory so I can visit my grandkids and have a longer, more productive life. People who get this testing done can change their own trajectory and do prehabilitation before any surgeries they may have, and I think that will also lead to better outcomes.
Mary Patterson: With the findings on modifiable risk factors that have come to the forefront over the past couple of decades, patients can benefit from understanding that about 45% of risk is self-determined and can be very goal oriented. The list can be exhaustive, and it lends itself to all other disease stages. What’s good for the heart is good for the brain. It can be a long list, but even if you start with something like reducing your alcohol consumption or lowering your BMI,
[00:20:00]
Mary Patterson: whatever is the most accessible risk factor on the list is a good starting point. That’s the approach we like to lead with.
Dr. David Drover: Right. People can struggle with all that list I gave. But even if they tackle one thing at a time, or only one thing, I think they’ll see a positive outcome in the long run. Having an idea of where their brain stands and what that trajectory is can be really helpful.
Mary Patterson: Absolutely. Dr. Drover, thank you so much for sharing your time and perspective for the first of our Cognitive Care Series. To everyone watching, thank you for joining us. If you’d like to learn more about cognitive care and how BrainCheck supports it, please visit braincheck.com. Hopefully we’ll see you for our next customer interview to continue learning alongside us.
Written by Mary Patterson, M.S.
VP of Clinical & Regulatory at BrainCheck
Mary Patterson is a clinical and operational leader with more than a decade of experience advancing medical technologies through clinical research and regulatory strategy. Her expertise spans neuroscience, Alzheimer’s disease, and neurovascular research, with a focus on translating evidence-based science into regulated, real-world medical products.